714 related articles for article (PubMed ID: 29125546)
1. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
[TBL] [Abstract][Full Text] [Related]
2. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
Gao C; Higgins PJ; Zhang W
Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
[TBL] [Abstract][Full Text] [Related]
3. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
Devuyst O
Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
[TBL] [Abstract][Full Text] [Related]
4. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic diabetes insipidus.
Bichet DG
Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.
Moeller HB; Rittig S; Fenton RA
Endocr Rev; 2013 Apr; 34(2):278-301. PubMed ID: 23360744
[TBL] [Abstract][Full Text] [Related]
7. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic diabetes insipidus.
Bichet DG
Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
[TBL] [Abstract][Full Text] [Related]
9. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of nephrogenic diabetes insipidus.
Hureaux M; Vargas-Poussou R
Mol Cell Endocrinol; 2023 Jan; 560():111825. PubMed ID: 36460218
[TBL] [Abstract][Full Text] [Related]
11. Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.
Sasaki S; Chiga M; Kikuchi E; Rai T; Uchida S
Clin Exp Nephrol; 2013 Jun; 17(3):338-44. PubMed ID: 23150186
[TBL] [Abstract][Full Text] [Related]
12. [Nephrogenic diabetes insipidus].
Evrard A; Lefebvre J; Vantyghem M
Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic Diabetes Insipidus.
Balla A; Hunyady L
Exp Suppl; 2019; 111():317-339. PubMed ID: 31588538
[TBL] [Abstract][Full Text] [Related]
15. Congenital nephrogenic diabetes insipidus: the current state of affairs.
Wesche D; Deen PM; Knoers NV
Pediatr Nephrol; 2012 Dec; 27(12):2183-204. PubMed ID: 22427315
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
Makretskaya NA; Nanzanova US; Hamaganova IR; Eremina ER; Tiulpakov AN
Probl Endokrinol (Mosk); 2023 May; 69(2):75-79. PubMed ID: 37448274
[TBL] [Abstract][Full Text] [Related]
17. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
Ding C; Beetz R; Rittner G; Bartsch O
Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
[TBL] [Abstract][Full Text] [Related]
18. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
Loonen AJ; Knoers NV; van Os CH; Deen PM
Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
[TBL] [Abstract][Full Text] [Related]
19. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
Morin D
Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin-aquaporin-2 pathway: recent advances in understanding water balance disorders.
Ranieri M; Di Mise A; Tamma G; Valenti G
F1000Res; 2019; 8():. PubMed ID: 30800291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]